GLP-1 medications are meant to be long-term treatments for diabetes or obesity
No food competing for blood flow
Limitations and Considerations BMI cutoff used is in between the typical cutoffs for overweight and obese Limited generalizability given that the majority of patients included were Caucasian, with only 12.5% African American male predominant population studied, with only 27.7% females It remains to be demonstrated if treatment with semaglutide has a cardioprotective and preventative benefit in patients who do not have pre-existing cardiovascular disease PowellWiley TM, Poirier P, Burke LE, et al
The main confirmed actions were documented as: stimulating insulin secretion (incretin effect), inhibiting glucagon secretion, inhibiting gastrointestinal motility and secretion (enterogastrone / ileal brake mechanism), and regulating appetite and food intake
4. Finish with Moisturizer or SPF
Note: Ozempic does not cause sulfur burps in everyone and is not among its common side effects